UK pharma wants NICE's role evaluated
This article was originally published in SRA
Executive Summary
The UK R&D pharmaceutical industry association, the ABPI, has called for a debate on the role of the National Institute for Health and Clinical Excellence at the same time as the government begins talks on how medicines will be reimbursed in future1.